Danaher (NYSE:DHR – Get Free Report) had its price target lowered by JPMorgan Chase & Co. from $310.00 to $300.00 in a research note issued on Tuesday. The brokerage currently has an “overweight” rating on the conglomerate’s stock. JPMorgan Chase & Co.‘s price objective indicates a potential upside of 20.80% from the stock’s current price.
A number of other research analysts have also recently issued reports on DHR. Evercore ISI lifted their price objective on shares of Danaher from $275.00 to $278.00 and gave the company an “outperform” rating in a research note on Tuesday, October 1st. Barclays cut their target price on Danaher from $285.00 to $275.00 and set an “equal weight” rating on the stock in a research report on Wednesday, October 23rd. StockNews.com lowered Danaher from a “buy” rating to a “hold” rating in a report on Saturday, December 14th. Scotiabank assumed coverage on shares of Danaher in a report on Monday, December 23rd. They issued a “sector perform” rating and a $265.00 price target on the stock. Finally, Raymond James dropped their price objective on shares of Danaher from $300.00 to $275.00 and set an “outperform” rating on the stock in a report on Tuesday, January 21st. Six research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $285.81.
Read Our Latest Stock Report on DHR
Danaher Stock Down 0.9 %
Institutional Trading of Danaher
Several institutional investors and hedge funds have recently modified their holdings of DHR. FMR LLC increased its position in Danaher by 15.8% in the third quarter. FMR LLC now owns 23,617,424 shares of the conglomerate’s stock worth $6,566,116,000 after purchasing an additional 3,217,631 shares during the last quarter. Massachusetts Financial Services Co. MA increased its position in shares of Danaher by 17.6% during the third quarter. Massachusetts Financial Services Co. MA now owns 3,582,982 shares of the conglomerate’s stock worth $996,141,000 after acquiring an additional 535,254 shares during the period. International Assets Investment Management LLC raised its position in Danaher by 40,196.5% during the 3rd quarter. International Assets Investment Management LLC now owns 429,964 shares of the conglomerate’s stock valued at $119,539,000 after purchasing an additional 428,897 shares in the last quarter. Montrusco Bolton Investments Inc. grew its holdings in Danaher by 30.4% during the 3rd quarter. Montrusco Bolton Investments Inc. now owns 1,705,884 shares of the conglomerate’s stock worth $465,617,000 after acquiring an additional 397,671 shares in the last quarter. Finally, Union Bancaire Privee UBP SA purchased a new position in Danaher during the fourth quarter valued at approximately $74,551,000. 79.05% of the stock is currently owned by institutional investors.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Featured Articles
- Five stocks we like better than Danaher
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- What Does the Future Hold for Eli Lilly?
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
- Stock Splits, Do They Really Impact Investors?
- 3 Consumer Stocks Call Option Traders Are Betting Big On
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.